InnoSer joins the Eurostars funded project ‘LEMONAID’

InnoSer joins the Eurostars funded project ‘LEMONAID’

May 21, 2020

LEMONAID takes on the challenge of developing a new drug against Diffuse Large B-Cell Lymphoma (DLBCL) tumors to ultimately reduce drug resistance and relapse potential for patients. InnoSer supports this ambition by its expertise in combined in-vitro and in-vivo...
InnoSer meets you at knowledge for growth event

InnoSer meets you at knowledge for growth event

Apr 30, 2020

Organized by flanders.bio since it’s establishment in 2004, knowledge for growth brings over 1300 biotech, pharma, medtech, agricultural and chemical industry experts and decision makers, as well as investors, universities, topnotch research institutes,...
InnoSer welcomes Wim Tiest as its Chief Technology Officer

InnoSer welcomes Wim Tiest as its Chief Technology Officer

Apr 13, 2020

As of April 2020, Wim Tiest has joined InnoSer in the role of Chief Technology Officer (CTO) and as part of the company management team. Wim holds a MSc in biochemical engineering and in artificial intelligence, both from the KU Leuven. He has built his professional...
PDX/O oncology platform developments at InnoSer

PDX/O oncology platform developments at InnoSer

Apr 7, 2020

Despite the challenging times for the life sciences sector during coronavirus restrictions, we’ve been fortunate enough and well prepared to continue with the development of our PDX/O platform for oncology research. On a weekly basis we receive patient tumor samples...